TCL Archive Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules July 30, 1999
TCL Archive Varmus To Cut Five Percent From Cancer Centers As NCI Adjusts To “Financial disaster” May 6, 2011
TCL Archive ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent. March 21, 2008
TCL Archive In Brief: Five Institutions To Test Interferon; Appendectomy-Cancer Association Noted October 27, 1978
